COVID-19

The concept of treatment of the lungs of a patient infected with coronavirus
MedTech

FDA clears Aptitude’s Metrix molecular dx to test for COVID

The FDA granted Aptitude its first 510(k) clearance for the California-based dx-maker's next-generation Metrix COVID test.
Joseph Keenan Sep 18, 2026 8:55am
handshake deal shake hand arrows ok yes
Favicon Fierce Pharma

Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals

Apr 6, 2026 8:37am
An arrow incrementally going up stairs before pointing straight up Blue background

Cyrano noses toward pivotal trial after midphase smell loss win

Feb 17, 2026 10:15am
change direction new plan alter arrows move reprioritize

AstraZeneca relaxed about relaxin drug's poor efficacy in ph. 2

Feb 10, 2026 7:50am
FDA

FDA names Tracy Beth Høeg as acting head of drug center

Dec 4, 2025 4:03am
3D rendering of SARS-CoV-2 virus particles

Dynavax pays Vaxart $30M for oral COVID-19 vaccine program

Nov 6, 2025 5:50am
More News

Pfizer pulls the plug on 11 programs

Nov 4, 2025 2:40pm

Edesa claims survival win for phase 3 respiratory failure trial

Oct 28, 2025 9:45am

Abbott device growth offsets diagnostics sales slide in Q3

Oct 15, 2025 11:00am
Fierce Pharma

ACIP narrowly votes against COVID vaccine prescriptions

Sep 19, 2025 5:22pm